Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuron (IMRN) Common Equity (2016 - 2025)

Immuron has reported Common Equity over the past 10 years, most recently at $5.2 million for Q2 2025.

  • For Q2 2025, Common Equity fell 38.3% year-over-year to $5.2 million; the TTM value through Jun 2025 reached $5.2 million, down 38.3%, while the annual FY2025 figure was $5.2 million, 37.26% down from the prior year.
  • Common Equity for Q2 2025 was $5.2 million at Immuron, down from $6.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $18.9 million in Q4 2021 and troughed at $114095.9 in Q4 2023.
  • A 5-year average of $7.5 million and a median of $6.8 million in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: skyrocketed 6509.72% in 2021 and later tumbled 99.25% in 2023.
  • Year by year, Common Equity stood at $18.9 million in 2021, then decreased by 19.28% to $15.2 million in 2022, then tumbled by 99.25% to $114095.9 in 2023, then skyrocketed by 5826.24% to $6.8 million in 2024, then dropped by 23.57% to $5.2 million in 2025.
  • Business Quant data shows Common Equity for IMRN at $5.2 million in Q2 2025, $6.8 million in Q4 2024, and $127094.4 in Q3 2024.